A common technique in CBT (Cognitive Behavior Therapy) is to challenge assumptions, turn black and white beliefs into a continuum of gray. This allows for a wider range of response behaviors compared to all or nothing.
In that spirit, I suggest that when health officials have the opportunity to obtain reliable data that they do so rather rely on assumptions.
A specific opportunity now is to test the notion of the "21 day quarantine and clear" policy. In terms of disease process does this mean that if a person does not develop symptoms within 21 days then they were never infected? they escaped exposure? or does it mean that the viral load exposure was low enough for this persons that they successfully fought the infection to prevent disease? This distinction is important because it steers us to focus on avoiding exposure or enhancing early interventions (or of course do both). Additionally this could imply if the person initially fought off infection for 21 days but a week or tow later developed influenza and compromised their immune response the original remnants of the Ebola infection could flare up.
So - how do we test this situation ?
One strategy is to study the people who were on monitoring but now 21 days clear. Test their blood with rt-pcr for any evidence of virions and also test IgM for early immune response. For those who received plasma transfusion I believe the IgM IgG ratios will help to distinguish the contribution of the plasma transfusion. If you find an IgM response then we have evidence the person was exposed but warded off disease.
For a small number (<8 people) and with their permission, the process could be done publicly. Or the institutions could expedite IRB review and get the studies done within the week.
Of course there will be some costs and logistics with questions on who pays etc - but it in my opinion the pay off of validation trumps the costs of speculation (ie the cost of failed assumptions).
Hopefully we will see questions and processes as above in the media soon.
Thornton
In that spirit, I suggest that when health officials have the opportunity to obtain reliable data that they do so rather rely on assumptions.
A specific opportunity now is to test the notion of the "21 day quarantine and clear" policy. In terms of disease process does this mean that if a person does not develop symptoms within 21 days then they were never infected? they escaped exposure? or does it mean that the viral load exposure was low enough for this persons that they successfully fought the infection to prevent disease? This distinction is important because it steers us to focus on avoiding exposure or enhancing early interventions (or of course do both). Additionally this could imply if the person initially fought off infection for 21 days but a week or tow later developed influenza and compromised their immune response the original remnants of the Ebola infection could flare up.
So - how do we test this situation ?
One strategy is to study the people who were on monitoring but now 21 days clear. Test their blood with rt-pcr for any evidence of virions and also test IgM for early immune response. For those who received plasma transfusion I believe the IgM IgG ratios will help to distinguish the contribution of the plasma transfusion. If you find an IgM response then we have evidence the person was exposed but warded off disease.
For a small number (<8 people) and with their permission, the process could be done publicly. Or the institutions could expedite IRB review and get the studies done within the week.
Of course there will be some costs and logistics with questions on who pays etc - but it in my opinion the pay off of validation trumps the costs of speculation (ie the cost of failed assumptions).
Hopefully we will see questions and processes as above in the media soon.
Thornton
Comment